These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8729651)

  • 1. Determination of salmeterol in metered-dose and dry-powder inhalers by reversed-phase high performance liquid chromatography.
    Nayak VG; Belapure SG; Gaitonde CD; Sule AA
    J Pharm Biomed Anal; 1996 Feb; 14(4):511-3. PubMed ID: 8729651
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.
    Jessen S; Becker V; Rzeppa S; Backer V; Bengtsen KH; Hullstein I; Dehnes Y; Hostrup M
    Drug Test Anal; 2021 Apr; 13(4):747-761. PubMed ID: 33210444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of salmeterol in rat and dog plasma by high-performance liquid chromatography with fluorescence detection.
    Colthup PV; Young GC; Felgate CC
    J Pharm Sci; 1993 Mar; 82(3):323-5. PubMed ID: 8095543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of exercise-induced bronchospasm in pediatric asthma patients: A comparison of two salmeterol powder delivery devices.
    Bronsky EA; Pearlman DS; Pobiner BF; Scott C; Wang Y; Stahl E
    Pediatrics; 1999 Sep; 104(3 Pt 1):501-6. PubMed ID: 10469776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupled column chromatography in chiral separation of salmeterol.
    Kim KH; Yun HW; Kim HJ; Park HJ; Choi PW
    Arch Pharm Res; 1998 Apr; 21(2):212-6. PubMed ID: 9875433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
    Campbell LM; Anderson TJ; Parashchak MR; Burke CM; Watson SA; Turbitt ML
    Respir Med; 1999 Apr; 93(4):236-44. PubMed ID: 10464887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol.
    Lipworth BJ; Aziz I
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):88-92. PubMed ID: 9893190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices.
    Barry PW; O'callaghan C
    Br J Clin Pharmacol; 1999 Apr; 47(4):357-60. PubMed ID: 10233197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers.
    Lipworth BJ; Fardon TC
    J Allergy Clin Immunol; 2004 Jan; 113(1):178; author reply 178-9. PubMed ID: 14713929
    [No Abstract]   [Full Text] [Related]  

  • 10. Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
    Murnane D; Martin GP; Marriott C
    J Pharm Sci; 2009 Feb; 98(2):503-15. PubMed ID: 18506819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma.
    Bronsky EA; Kemp JP; Orgel HA; Bierman CW; Tinkelman DG; van As A; Liddle RF
    Chest; 1994 Apr; 105(4):1032-7. PubMed ID: 7909285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dry powder versus nebulized beta-agonist in patients with COPD who have suboptimal peak inspiratory flow rate.
    Mahler DA; Waterman LA; Ward J; Gifford AH
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):103-9. PubMed ID: 23745526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of salmeterol in childhood asthma.
    Lenney W; Pedersen S; Boner AL; Ebbutt A; Jenkins MM
    Eur J Pediatr; 1995 Dec; 154(12):983-90. PubMed ID: 8801107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group.
    Jones KP
    Thorax; 1994 Oct; 49(10):971-5. PubMed ID: 7974313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The determination in human plasma of 1-hydroxy-2-naphthoic acid following administration of salmeterol xinafoate.
    Chilton AS; Godward RE; Carey PF
    J Pharm Biomed Anal; 1995 Feb; 13(2):165-9. PubMed ID: 7766724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of protection by inhaled salmeterol in exercise-induced asthma.
    Anderson SD; Rodwell LT; Du Toit J; Young IH
    Chest; 1991 Nov; 100(5):1254-60. PubMed ID: 1682113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pulmonary function and pharmacokinetics of fluticasone propionate and salmeterol xinafoate delivered by two dry powder inhalers to patients with asthma.
    Harrison LI; Novak CC; Needham MJ; Ratner P
    J Aerosol Med Pulm Drug Deliv; 2011 Oct; 24(5):245-52. PubMed ID: 21671752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for asthma.
    Med Lett Drugs Ther; 2000 Mar; 42(1073):19-24. PubMed ID: 10755001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.